Research article

Understanding the oscillations of an epidemic due to vaccine hesitancy

  • Received: 28 January 2024 Revised: 19 June 2024 Accepted: 17 July 2024 Published: 09 August 2024
  • Vaccine hesitancy threatens to reverse the progress in tackling vaccine-preventable diseases. We used an SIS model with a game theory model for vaccination and parameters from the COVID-19 pandemic to study how vaccine hesitancy impacts epidemic dynamics. The system showed three asymptotic behaviors: total rejection of vaccinations, complete acceptance, and oscillations. With increasing fear of infection, stable endemic states become periodic oscillations. Our results suggest that managing fear of infection relative to vaccination is vital to successful mass vaccinations.

    Citation: Anthony Morciglio, R. K. P. Zia, James M. Hyman, Yi Jiang. Understanding the oscillations of an epidemic due to vaccine hesitancy[J]. Mathematical Biosciences and Engineering, 2024, 21(8): 6829-6846. doi: 10.3934/mbe.2024299

    Related Papers:

    [1] Glenn Ledder . Incorporating mass vaccination into compartment models for infectious diseases. Mathematical Biosciences and Engineering, 2022, 19(9): 9457-9480. doi: 10.3934/mbe.2022440
    [2] Pannathon Kreabkhontho, Watchara Teparos, Thitiya Theparod . Potential for eliminating COVID-19 in Thailand through third-dose vaccination: A modeling approach. Mathematical Biosciences and Engineering, 2024, 21(8): 6807-6828. doi: 10.3934/mbe.2024298
    [3] Bruno Buonomo, Alberto d’Onofrio, Deborah Lacitignola . Rational exemption to vaccination for non-fatal SIS diseases: Globally stable and oscillatory endemicity. Mathematical Biosciences and Engineering, 2010, 7(3): 561-578. doi: 10.3934/mbe.2010.7.561
    [4] Beatriz Machado, Liliana Antunes, Constantino Caetano, João F. Pereira, Baltazar Nunes, Paula Patrício, M. Luísa Morgado . The impact of vaccination on the evolution of COVID-19 in Portugal. Mathematical Biosciences and Engineering, 2022, 19(1): 936-952. doi: 10.3934/mbe.2022043
    [5] Tetsuro Kobayashi, Hiroshi Nishiura . Prioritizing COVID-19 vaccination. Part 2: Real-time comparison between single-dose and double-dose in Japan. Mathematical Biosciences and Engineering, 2022, 19(7): 7410-7424. doi: 10.3934/mbe.2022350
    [6] Xiaojing Wang, Yu Liang, Jiahui Li, Maoxing Liu . Modeling COVID-19 transmission dynamics incorporating media coverage and vaccination. Mathematical Biosciences and Engineering, 2023, 20(6): 10392-10403. doi: 10.3934/mbe.2023456
    [7] Chuanqing Xu, Xiaotong Huang, Zonghao Zhang, Jing'an Cui . A kinetic model considering the decline of antibody level and simulation about vaccination effect of COVID-19. Mathematical Biosciences and Engineering, 2022, 19(12): 12558-12580. doi: 10.3934/mbe.2022586
    [8] ZongWang, Qimin Zhang, Xining Li . Markovian switching for near-optimal control of a stochastic SIV epidemic model. Mathematical Biosciences and Engineering, 2019, 16(3): 1348-1375. doi: 10.3934/mbe.2019066
    [9] Fang Wang, Lianying Cao, Xiaoji Song . Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination. Mathematical Biosciences and Engineering, 2022, 19(8): 8035-8056. doi: 10.3934/mbe.2022376
    [10] Yuto Omae, Yohei Kakimoto, Makoto Sasaki, Jun Toyotani, Kazuyuki Hara, Yasuhiro Gon, Hirotaka Takahashi . SIRVVD model-based verification of the effect of first and second doses of COVID-19/SARS-CoV-2 vaccination in Japan. Mathematical Biosciences and Engineering, 2022, 19(1): 1026-1040. doi: 10.3934/mbe.2022047
  • Vaccine hesitancy threatens to reverse the progress in tackling vaccine-preventable diseases. We used an SIS model with a game theory model for vaccination and parameters from the COVID-19 pandemic to study how vaccine hesitancy impacts epidemic dynamics. The system showed three asymptotic behaviors: total rejection of vaccinations, complete acceptance, and oscillations. With increasing fear of infection, stable endemic states become periodic oscillations. Our results suggest that managing fear of infection relative to vaccination is vital to successful mass vaccinations.



    Vaccination is one of the most cost-effective ways of avoiding disease—it prevents 2–3 million deaths a year, and a further 1.5 million could be avoided if global coverage of vaccinations improved [1]. The recent COVID-19 pandemic, caused by SARS-CoV-2, presented an unprecedented challenge to human health, the economy, and nearly all aspects of our society. Vaccination, social distancing, and mask-wearing are effective mitigation methods to prevent widespread morbidity and mortality from the infection. The rapid development of effective vaccinations was one of the longstanding legacies of the COVID-19 pandemic.

    Mass vaccination for COVID-19 started on December 14, 2020 in the United States [2], leading to a significant reduction of infections and disease burden within vaccinated populations [3]. As the vaccination programs progressed into March 2021, a widespread reduction in cases and deaths [4] led to the relaxation of non-pharmaceutical interventions in many places [5].

    However, vaccine hesitancy, a strong unwillingness to adopt vaccination [6,7], remains a persistent barrier to complete population inoculation against highly infectious diseases. "It is difficult to comprehend that some of the greatest triumphs of medical science are being eroded by misinformation and distrust." [8]. As COVID-19 vaccination efforts went underway worldwide, significant vaccine hesitancy and resistance were observed even among healthcare workers [9,10]. Multi-country surveys have shown wide country-to-country variation in vaccine acceptance (31–89%) [11,12]. Another international study using data from 13 countries showed a concerning trend: As the pandemic progressed, the percentage of people intending to refuse vaccination increased [13]. In the UK, a large survey of 5114 adults in October 2020 showed 16.6% were "very unsure", and 11.7% were "strongly hesitant" [14]. An excellent model fit explaining 86% of the variance in hesitancy "was provided by beliefs about the collective importance, efficacy, side-effects, and speed of development of a COVID-19 vaccine."[14] In Japan, a country with more than 75% vaccination rate, nearly 4% of the people surveyed switched from being willing to be vaccinated to being hesitant between February 2021 and February 2022 [15]. A more recent analysis of Polish COVID-19 vaccination data (until January 2023) showed a general decline in subsequent vaccine uptake even after increased government-provided doses, which led them to recommend significant changes in official vaccination policies [16].

    There are many possible reasons for vaccine hesitancy [17], including concerns about the safety and side effects of the vaccine. Some studies suggest that belief in conspiracy theories drives vaccination hesitancy through exposure to misinformation [18,19]. Even medically informed individuals rely on a personal risk–benefit perception that may be influenced by misinformation regarding vaccine safety [9]. Distrust in the scientific expertise and health and government authorities drives consumers from "traditional" sources (newspapers, television, radio, government agencies) to social media outlets [20], who are then more likely subject to misinformation. Misinformation has been shown to correlate with vaccine hesitancy, even though the causal relationship has yet to be established [18,19].

    Our goal is to develop a model to help understand vaccine hesitancy's mechanistic role in the spread of infections. Meant to explore the essentials of a system that can accommodate both stable endemic equilibria and periodic oscillations of high/low infections, our model does not address the underlying causes for vaccine hesitancy, nor attempt to reproduce the COVID-19 pandemic spread quantitatively. The key ingredient here is an evolutionary game theoretical framework for aggregate decision-making on vaccination with a susceptible-infected-susceptible (SIV) model for epidemic spread, which we call the SIV model. We show analytically and numerically that the competition between the fear of vaccination and the perceived risk of infection introduced in our model, may drive the system into a stable endemic equilibrium or dynamic oscillations of the epidemic.

    The simplest epidemic model considers a well-mixed population, a fraction of which are susceptible (S) to the infection, and the rest being infected and infectious (I=1S). The transmission rate is β, and the infected recover at the rate γ. Known as the SIV model, this system evolves in time (t) according to the equation: ˙S=dS/dt=γIβIS (or ˙I=βSIγI). In general, if β>γ (infection faster than recovery), the system settles into the disease endemic state with a fraction of susceptible at γ/β and infectious at 1γ/β. Otherwise, the system eventually arrives at a disease-free, stable, steady state with I=0. This disease-free steady state loses stability when β>γ or R0=β/γ>1. The SIV model generally applies to diseases where infection does not confer long-term immunity, such as the common cold, influenza, or herpes. Considering the repeated emergence of new viral variants of SARS-CoV-2 (BA.1, Omicron, EG.5...) that render existing immunity less effective, and knowing that previously infected people can become infected again, the SIV model is a reasonable minimal model for the SARS-CoV-2 epidemics.

    To study the effects of vaccination in the SIV model, we further divide the population into a third fraction, V, representing the vaccinated people (Figure 1A). Two parameters associated with V are ˉβ, the breakthrough infection rate (the likelihood of a vaccinated individual becoming re-infected), and ϕ, the willingness of a susceptible individual to take the vaccine. Considering the non-trivial feedback of the epidemic into the vaccine willingness, we assume that the probability of vaccination uptake, ϕ, depends on the risk perception of infection and vaccination.

    Figure 1.  The SIV model. (A) Schematic representation of the SIV model: the susceptible S becomes infected at infection rate β and vaccinated with probability ϕ. The vaccinated become re-infected at breakthrough infection rate ˉβ, while the infected recover at rate γ. (B) The triangular prism representation of the 3D phase space: the S, I, V phase space as a triangle, with the vertices being S,I,V=1, and the linear dimension corresponds to ϕ[0,1] from bottom to top.

    We use the simplest form of a vaccination game [21] under the presumption of uniform information exchange. Susceptible individuals can choose one of two strategies, either vaccinate (V) or not. The latter means they take a chance to become infected (I). The payoff of the strategies chosen by a susceptible individual depends on the relative strategies selected by others in the population. Denoting rv and ri as the risk perceptions associated with vaccination and infection, respectively, the equation for how ϕ changes can be expressed as

    ˙ϕ=ϕ×(1ϕ)×[rvV+riI].

    Here ΔE=rvV+riI is the marginal expectation difference between the two strategies [21,22,23]. Because scaling the payoff matrix does not change the qualitative dynamics of the game [23,24], the marginal expectation difference can be expressed as

    ΔE=fI(1f)V,

    where friri+rv is dimensionless. For simplicity, we call ΔE the "fear factor" and that plays a similar role to the incentive to vaccinate, while the fractions f and 1f are associated with the relative fear of infection and vaccination, respectively. We will show that ΔE has a significant impact on the oscillatory behavior of infection and vaccination.

    The system of equations of the SIV model is:

    ˙S=γIβSIϕS (2.1)
    ˙I=βSIγI+ˉβIV (2.2)
    ˙V=ϕSˉβIV (2.3)
    ˙ϕ=ϕ(1ϕ)ΔE (2.4)

    Because we do not consider immigration, population growth, and death, the population is conserved, S+I+V=1, and the model can be reduced to three state variables by rewriting S=1(I+V). Figure 1 illustrates the box-and-arrow diagram and a triangular prism representing the three-dimensional (3D) phase space for the solutions.

    The system of three ordinary differential equations, involving I,V, and ϕ, is non-trivial to analyze, even though it is straightforward to show that trajectories starting on the boundary (a side, edge, or vertex) of the prism can either remain in those domains or move into the prism. We study this model numerically and analytically to determine how I, V, and ϕ change over time within the prism. We limit ourselves to a reasonable estimate of the infection rate for susceptible, β=0.15 (in units of 1/day), the infection recovery rate γ=0.07 (1/day) for COVID-19, such that R0=2.1 for the earlier variants of SARS-CoV-2 [25,26].

    To study the effects of the vaccine, we consider a breakthrough infection and focus on the dynamics of the epidemic due to vaccine hesitancy by varying the fear factor f. Numerous studies estimated the breakthrough infection rate for SARS-CoV-2 vaccines [27,28]. In the US, UK, Brazil, South Africa, and Israel, the breakthrough infection rates have been estimated to be roughly 40% to 77% of the normal infection rate, hence our choice of breakthrough infection rate of ˉβ=0.05. It should be noted that the breakthrough infection depends on a multitude of factors, including vaccine type, number of doses, time after vaccination, virus variant, and individual immune response (older individuals have weakened immune systems and are more likely to become re-infected) [29,30,31]. Thus, varying ˉβ coincides with exploring different scenarios with variable vaccination efficacy due to the aforementioned factors. The incorporation of breakthrough infection is applied to consider the timeline for waning infection and reduced transmissibility between vaccinated and susceptible individuals. Indeed, the likelihood of transmission is reduced for vaccinated individuals [32], yet it could depend on the variant or the number of vaccines received, and age group [30,31]. Our choice of ˉβ lies between the intrinsic recovery rate γ and the normal infection rate β. Unless otherwise stated, we will use these baseline parameter values (Table 1) in our numerical simulations.

    Table 1.  Baseline parameters for the numerical simulations throughout the paper unless otherwise stated.
    Parameter Description Value
    β Infection rate for susceptible 0.15
    ˉβ Breakthrough infection rate for vaccinated 0.05
    γ Recovery rate 0.07
    f Fear of infection [0,1]

     | Show Table
    DownLoad: CSV

    Seeking steady states, we set the right-hand sides of Eqs (2.1)–(2.4) to zero. These define the nullclines of 2D surfaces within the 3D prism. The most relevant nullclines to explore vaccine hesitancy are associated with ˙ϕ=0, namely, ϕ=0,ϕ=1, or ΔE=0. These nullclines correspond to three branches of distinct behaviors. We label the bottom plane of the prism (ϕ=0) as the "total rejection" branch and the top plane (ϕ=1) as the "full acceptance" branch. More generally, when the epidemic is perceived to be severe, there is less vaccination hesitancy, and ϕ increases. Conversely, if the epidemic is mild and few are infected, the perceived fear of infection is low, and ϕ decreases. Because ϕ is driven up or down by the sign of ΔE, oscillatory behavior can quickly emerge from this feedback mechanism between the fear of infection and the fear of vaccination. Therefore, we label this third part of this nullcline (ΔE=0, a vertical plane in our prism) as the "oscillation" branch.

    Along with ˙ϕ=0, the other nullclines (˙I=0 and ˙V=0),

    I=0 or γ=βS+ˉβV (3.1)
    ϕS=ˉβIV (3.2)

    intersect at fixed points, with values denoted by I,V, and ϕ (and S=1IV) for convenience. We will examine the stability properties of these fixed points by their respective Jacobian matrix:

    J=(βI(βˉβ)I0ϕˉβVϕˉβI1IVfϕ(1ϕ)(f1)ϕ(1ϕ)(12ϕ)(fI(1f)V)) (3.3)

    This plane is characterized by ϕ0, i.e., no susceptible individuals are willing to be vaccinated. Thus, if no one in the population is vaccinated to begin with, V will remain zero. However, even if the system is initiated with some fraction of V's, that fraction can only decrease (via breakthrough infections) and end up at V=0. With V removed from the system, the dynamics reverts back to that of the trivial SIV model, i.e., ending at the endemic stable steady state (provided β>γ):

    S0γ/β;I01γ/β.

    We illustrate this scenario in Figure 2, where multiple initial conditions converge to this stable endemic state. Exceptions include the unrealistic case of 100% efficacy (ˉβ=0) and when I exponentially decays with time t and the entire population becomes vaccinated and permanently immune (equivalent to R in a SIR model). In the latter case, I is so mild that the epidemic would end even without vaccination.

    Figure 2.  The dynamics of total rejection is reducible to the standard SIV model, and the trajectories robustly converge to the endemic equilibrium. A) Temporal dynamics of 8 random initial conditions. All variables asymptotically approach the endemic equilibrium of finite infection and zero vaccination, equivalent to the SIV model. B) Trajectories in the S-I phase plane where the S and I nullclines are in red and blue, respectively.

    Next, we study small perturbations from this plane, i.e., ϕ1. It is clear from Eq (2.4) that such perturbations will either decay or grow, depending on the sign of ΔE. For example, the likelihood of a susceptible individual will choose to be vaccinated increases when there are many infected individuals (I), as the fear of infection becomes greater than the fear of vaccination. Quantitatively, we carry out a linear stability analysis and note that J is triangular with eigenvalues βI0,βI0,fI0. Thus, although the bottom plane is unstable, this fixed point is stable within the bottom plane. Trajectories approaching the rest of the plane (away from the fixed point) will either be attracted or repelled to the plane, depending on the sign of the fear factor ΔE.

    The total acceptance (ϕ1) branch corresponds to the top plane of the prism. Trajectories that start from this plane never leave and, as may be expected, always end at the V=1 vertex. To confirm this scenario, we first consider the nullclines to seek a steady state in the plane.

    The second part of Eq (3.1) specifies a straight line that joins the point S=γ/β on the V=0 edge and the point V=γ/ˉβ on the S=0 edge. Because we have chosen β,γ so that the former lies in the physical region, but the latter would lay outside if ˉβ<γ (indication of a good vaccine), this nullcline intersects the I=0 edge at S1=(γˉβ)/(βˉβ)=1V1. Meanwhile, since I=0 is also a nullcline, the physically meaningful ˙I=0 nullcline consists of both line segments: I=0 and I=I0(1ˉβ/β)V (red lines in Figure 3A), joined at (S1,V1).

    Figure 3.  The nullclines: A) Top plane. Red lines are the I-nullclines, Equation (3.1), and blue for the V-nullcline, Equation (3.2). The I0 red line connects S=γ/β along the V=0 line and V=γ/ˉβ along the S=0 line. γ/ˉβ lies outside the triangle for an efficacious vaccine and within the triangle for an ineffective vaccine. B) A possible scenario with extremely contagious infections (see text).

    The second nullcline is a hyperbola, as (ˉβI+1)(ˉβV+1)=1+ˉβ is an equivalent form for Eq (3.2). Symmetric in IV and "anchored" at the I and V vertices of the triangle, it bows out to a mid-point Im=Vm=[1+ˉβ1]/ˉβ (blue line in Figure 3). For parameters of interest (ˉβ<γ<β), the two nullclines meet at the stable steady state (V=1 vertex). Figure 4 provides an example illustrating this plane's typical evolution trajectories.

    Figure 4.  Dynamics of total acceptance (ϕ1) always end in the stable steady state of V=1. A) Temporal dynamics from 8 random initial conditions with f=0.50. B) Phase trajectories in the I-V phase plane with the I and V nullclines in red and blue, respectively.

    Mathematically, the V nullcline (blue hyperbola) can intersect the I nullcline (red line) at two other points (Figure 3B). This scenario can occur only for β>(1+ˉβ)/2. Keeping λ=0.07 and ˉβ=0.05, the minimum value of γ/β=0.022 for two intersections. This value corresponds to a R0=45.5, much larger than any known reproduction number of SARS-CoV-2. This number corresponds to an extremely contagious infection, much higher than for measles (R0>10 with a wide range [33]) or even the most contagious Omicron sub-variants (R0=9.5 [34]). Because our main interest is to study a population with vaccination choices and how it affects "moderately" transmissible pathogens, we will not analyze these possibilities further.

    Likewise, the two nullclines can intersect outside the feasible region if ˉβ>γ. This scenario corresponds to an ineffective vaccine that cannot end the epidemic even if the entire population accepts it. We do not analyze these scenarios and summarize the obvious: with full participation (ϕ=1), an efficacious vaccine (ˉβ>γ) will terminate an epidemic as long as the transmissibility is not too high (β<(1+ˉβ)/2).

    Within the top plane, every individual "accepts" the vaccine (ϕ=1) and the stable steady state is trivially the case of V=1. Such "total acceptance" is best interpreted as a compulsory vaccine (such as polio). Clearly, for this population, the fear factor ΔE plays no role as everyone takes the vaccine regardless of social factors such as risk perception and fear of unwarranted side effects. Not surprisingly, trajectories on this plane that start with either sign of ΔE converge robustly to V=1 (Figure 4). By contrast, ΔE plays a significant role away from this plane, as trajectories are attracted either towards the plane (when ΔE>0) or away from it (when ΔE<0).

    The third and most interesting branch is where trajectories oscillate across the ΔE=0 surface (the green plane in Figure 1B). A steady state represents a perception of balanced fears that satisfies

    fI=(1f)V (3.4)

    This equation leads us readily to the balanced fears steady state (BFSS):

    S=γfˉββfˉβ;I=(1f)(1S);V=f(1S);ϕ=ˉβIV/S (3.5)

    Note that these values are all physical (positive fractions) for the "realistic'' scenarios (βγˉβ). In particular, S[S0,S1] as f varies from 0 to 1.

    To understand how the BFSS changes as the fear of infection increases from 0 to 1, we start with the V=0 edge on the bottom plane: If someone has no fear of being infected, why would they bother taking a vaccine? Indeed, as f0, this fixed point approaches the one in the "total rejection" plane, which is equivalent to the SIV model (Table 2). On the other hand, when f=1, the infection is eradicated through mass vaccination. This corresponds to timely vaccination interventions when the population is educated on the health benefits of vaccines and vaccine hesitancy is suppressed. Algebraically, it is surprising that this fixed point returns to this plane as f1 (since ϕ1f).

    Table 2.  Steady states of the SIV model. OFP: ordinary fixed point, DFE: disease-free equilibrium, SV: susceptible vaccinated, FV: fully vaccinated, IV: infected vaccinated, BFSS: balanced fear steady state.
    Name S I V ϕ
    OFP γ/β 1γ/β 0 0
    DFE 1 0 0 0
    SV (γβ)/(βˉβ) 0 1(γβ)/(βˉβ) 0
    FV 0 0 1 1
    IV 0 1γ/ˉβ γ/ˉβ 1
    BFSS γˉβfβ¯βf (1f)(1γˉβfβ¯βf) f(1γˉβfβ¯βf) ˉβf(1f)(1S)2S

     | Show Table
    DownLoad: CSV

    To appreciate this scenario, consider a population with a strong fear of infection. They are more likely to accept the vaccine, driving V up and I down. Eventually, the vaccination prevalence is high enough such that ΔE changes sign and ϕ decreases and reaches a small value of ϕ. If the population is in a regime where the proportion of vaccination exceeds the susceptible such that βS+ˉβV<γ, then infections cannot regain their foothold, and the epidemic ends with I0. Indeed, a more interesting behavior is associated with this BFSS as we study its stability properties next.

    Consider the characteristic equation μ3Tμ2+CμD=0 for the matrix J with trace (T), cofactor (C), determinant (D), and the discriminant of the cubic equation Δ:

    T=[ϕ+(β+ˉβ)I], (3.6)
    C=[ϕ+βI{βˉβ(1f)(1ϕ)}V]ˉβI, (3.7)
    D=(βfˉβ)ˉβ(1ϕ)VI2 (3.8)
    Δ=18CDT4DT34C3+C2T227D2 (3.9)

    We see both T and D are negative everywhere, except for f0. Thus, we encounter a pair of complex eigenvalues, which indicate oscillatory behavior. The physical interpretation is clear: with any imbalance (ΔE0), ϕ is changed in order to restore that balance. But then, the system overshoots, leading to oscillations. The transition from a stable focus to an unstable one (a Hopf bifurcation) shows trajectories turn from spiraling into the fixed point to outward spirals ending in a stable limit cycle.

    To analyze this bifurcation, let us label the eigenvalues of J by Λ,λ±iω. In terms of these, we have T=Λ+2λ, C=2Λλ+λ2+ω2, and D=Λ(λ2+ω2), so that we can conclude Λ<0 from D<0. Further, for the regime where ω is real, the sign of λ is conveniently identical to that of the characteristic ΞTCD. Thus, by solving Ξ(γ,β,ˉβ,fc)=0, we can determine fc(γ,β,ˉβ), i.e., the critical f as a function of the parameter set (γ,β,ˉβ). For example, with our choice of (γ,β,ˉβ)=(0.07,0.15,0.05), we find fc0.58. For f>fc, the trajectories in our model end either in limit cycles or, for more extreme values of f, in fixed points in the boundary of the prism. To illustrate this transition, we present two cases: f=0.50,0.59 (Figures 5 and 6), where the trajectory spirals into a stable fixed point and a stable limit cycle.

    Figure 5.  A stable steady state for balanced fear in the vertical plane. A) Temporal dynamics with β=0.15, ¯β=0.05, γ=0.07, f=0.50. Inset shows a case with ffc. B) Phase trajectories, projected onto the I-V plane, converge to stable focus with a non-trivial ϕ.
    Figure 6.  Dynamics of a stable limit cycle around the unstable balanced fear fixed point, with f=0.5788. A) Temporal dynamics of oscillations close to the limit cycle. B) A trajectory near the limit cycle. C) A trajectory spiraling into the limit cycle from the "outside". D) A trajectory spiraling outward toward the limit cycle from the "inside". Arrows indicate the direction of the spiral. For clarity, we place a star at the starting points of the trajectories displayed.

    At the Hopf bifurcation, the frequency of the emerging limit cycle is ω=C, evaluated at this point. Though an explicit expression for ω(γ,β,ˉβ) is available, we do not reproduce it here, as it is cumbersome and provides little insight. Its numerical evaluation agrees with the results of simulation runs. In particular, we find that the period of the limit cycle starts at about 120 days for ffc, rising by a factor of about 3 when f0.9.

    Far above fc, it is common to find cycles in which the system spends a long time near the ϕ=0 plane. At some point in the cycle, with substantial V and little I, V trickles out very slowly (as we have a low rate of breakthrough infection, ˉβ) in a quasi-linear fashion so that I increases slowly. As soon as the I/V ratio passes (1f)/f, the point of balanced fear, ϕ rises precipitously. This rise drives V to increase rapidly (at the expense of S). As V surpasses I, the population changes its perception of the relative risks when (1f)V>fI (ΔE flips sign) and ϕ swings downwards. This swing is also relatively fast as ϕ approaches zero. An example is provided in the inset of Figure 5A. From a game theoretical perspective, the changing of signs of ΔE corresponds to the emergence of the non-trivial Nash equilibrium, where a small perturbation about ΔE=0 causes an oscillation in the frequency of strategy selection. The essential properties of such swings can be understood through a solvable toy model, which demonstrates the nature of the ϕ equation (details in Appendix).

    In a slightly more general form of the model, we can write ˙ϕ=δϕ(1ϕ)ΔE, where δ corresponds to the "strength of belief" and models how rapidly susceptible individuals get vaccinated when they decide to do so. The strength of belief mainly impacts the characteristic time of the oscillations (Figure 7B). The higher δ results in more rapid changes in ˙ϕ with oscillations in V and I in a more square shape.

    Figure 7.  Increasing the "strength of belief" makes steeper transitions. A) Temporal dynamics around the vertical plane fI=(1f)V. The two sets of traces correspond to different initial states. B, C) Phase trajectories for β=0.15,γ=0.07,ˉβ=0.0695, f=0.931, δ=10, with different initial values (denoted stars), projected onto the I-V plane. The former spirals inward into a stable limit cycle. The latter spirals outwards to the limit cycle. This scenario resembles the case of a low-efficacy vaccine where the population is not vaccine-hesitant.

    In other highly infectious diseases with different R0 values, as the fixed points in all three branches of the solutions depend on γ/β=1/R0, changing R0 will shift the steady state values without changing the overall dynamics. Most notably is the critical fear factor fc for oscillation depends on R0.

    Even when between 60% and 90% of the population is vaccinated, because of the low vaccination efficacy (ˉβγ), the breakthrough infection leads to fast spikes of infection followed by high vaccination uptake in response to the epidemic. This resembles the typical epidemic characteristic after a new viral variant emerges. Note that ˉβ>γ occurs only in the case of an ineffective vaccine.

    The COVID-19 pandemic caused over 7 million deaths worldwide and 1.2 million in the US alone (as of June 2024), more than vehicle crashes, gun violence, the flu, or many other public health threats combined [35,36]. The situation is unfortunate since many of these deaths could have been prevented if only more people had received vaccine shots. A recent study estimated that at least 232,000 deaths could have been prevented among unvaccinated adults during the 15 months in the US (from May 30, 2021 to September 3, 2022), had they been vaccinated with at least a primary series of vaccines [37]. Hence, accurate communication of valid scientific findings to the public and a decrease in the politicization of science are necessary.

    Our minimal SIV model adds a vaccine willingness to an SIV epidemic model and explores how vaccine hesitancy impacts the epidemic evolution. A substantial body of literature exists for more complex models that account for specific COVID-19 characteristics and data. Unfortunately, these complex models are often difficult to analyze and understand in terms of the underlying complex dynamics. For example, at the onset of the COVID-19 pandemic, many epidemiological models were rapidly adapted to emerging public health data and provided valuable support for policymakers to develop public health responses. In particular, the Center for Disease Control and Prevention (CDC) continues to use a large and growing list of such models to provide forecasts of new cases, hospitalizations, and deaths (https://www.cdc.gov/coronavirus/2019-ncov/science/forecasting/mathematical-modeling.html).

    Our simple model allowed for detailed analysis to shed new insights into how vaccine hesitancy can be a novel source of periodic oscillations in epidemic spread. We demonstrated that when vaccine willingness depends on the epidemic size, the disease-free equilibrium is only achievable in the case of total vaccine acceptance. On the other hand, in the case of total vaccine rejection, the epidemic invariably arrives at the endemic equilibrium with a finite infected population depending on the infection rate and recovery rate. In the more realistic case of intermediate vaccine hesitancy, the relative strength between the fear of infection and the fear of vaccine drives the epidemic progress. When the fear of infection is low, the epidemic settles into a steady state, with the number of people vaccinated proportional to the fear of infection and the number of people infected proportional to the fear of vaccination. Increasing the fear of infection, the system will cross a point where the fear of infection and vaccination balance out, and the system undergoes a Hopf bifurcation and enters periodic oscillations, eventually settling into a limit cycle. Many other studies have shown the existence of oscillations in COVID-19 modeling [38,39,40], but none of them studied vaccine hesitancy. Our minimal model offers novel insight into the role of vaccine hesitancy as a novel source of epidemic oscillation, and the challenges of achieving herd immunity via vaccination in the presence of vaccine hesitancy.

    There are innumerable avenues worthy of future research; only a few will be mentioned here. The present model has minimal parameters associated with various transition rates. Other rates that may affect the qualitative outcomes of the model include, e.g., births/deaths and waning immunity. In the latter, VS with an additional timescale. Similarly, we may incorporate more sophisticated ingredients to model the behavior of vaccine acceptance. Another extension of our simple model would be to include stochastic effects or formulate it as an agent-based model to incorporate an individual's history. Preliminary studies involving agent-based simulations revealed several interesting results, e.g., finite lifetimes of the endemic steady states (also known as lifetimes to extinction in the language of population dynamics).

    Our model consists of individuals who have the same information and use the information to assess relative risks, which is a simplification of information processing, selective exposure, and intrinsic bias due to one's political affiliation, media exposure, and social network [41,42,43]. A separate, network-based model for information transmission in addition to a physical network-based disease transmission would be desirable to capture the more realistic information dynamics.

    It is also possible to study fluctuations of and correlations between modeling parameters (e.g., transmission rates, recovery rate, and fear factor); both are absent from the analysis in this paper. Most diseases, especially SARS-CoV-2, affect different age groups differently. We can investigate in more details how an epidemic might spread and end by including age distributions. In general, only some people are in contact with everyone else in the population due to social and geographic constraints. Overlaying social and spatial structures on our model and investigating their effects could provide new insights. Finally, using agent-based models, we consider the much more realistic situation where there is a variety of responses (individual ϕ's) due to different levels of fear and misinformation.

    We believe that understanding how vaccine hesitancy and reluctance impact the progression of an epidemic can help to design better vaccine campaign strategies and shorten the duration of an epidemic.

    An analytically solvable toy model

    Here, we show a minimal model that can be solved analytically and may provide some insight into the oscillatory behavior in our model. Consider Eq (2.4) and the simplified equation for ΔE:

    ˙ΔE=B(A+B)ϕ (5.1)
    ˙ϕ=σϕ(1ϕ)ΔE (5.2)

    where A,B,σ are positive constants. Although these constants can be absorbed into scale factors of the variables and t, their explicit presence facilitates discussions here.

    This system of equations can be solved exactly, as in classical mechanics. To make the analogy explicit, let us think of a particle with unit mass moving in x[,]. In addition, motivated by dx=dϕ/ϕ(1ϕ), let us change variables to

    p=σΔEx=lnϕ1ϕ

    (An arbitrary x0 may be added to x, we choose it to be 0 when ϕ=1/2.) Then

    ϕ(x)=ex1+ex=1+tanhx2

    lies in [0,1]. Equations (5.1) and (5.2) become

    ˙x=p˙p=[B(A+B)ϕ(x)]/σ

    which displays classic Hamiltonian dynamics with

    H=p22+V(x)

    and the potential

    V(x)=σ[Ax+2(A+B)lncoshx2]

    For |x|x0, the potential V is almost linear, being σBx for x<0 and σAx for x>0. Keeping A,B constant and varying σ, we see that σ corresponds to the steepness of the V-shaped potential. We can verify that, given the same initial conditions (ΔE(0),ϕ(0)), a large σ will result in ϕ making rapid transitions from 0 to 1 (i.e., our particle oscillating between large positive and negative values of x). Meanwhile, the "momentum" changes sign at the bottom of V almost instantaneously, corresponding to the kink-like structures at extreme values of ΔE. When the trajectories take us to large values of x, the almost linear potential V resembles uniform gravity, leading to the momentum being linear in t. This aspect captures the essence of quasi-linear regions in a VI plot.

    Finally, the main advantage of this toy model is that it guarantees limit cycles. Indeed, this is a neutral system with an infinite number of limit cycles, labeled by the value of H, the total "energy" of our particle.

    Steady states

    We compute the steady states by setting Eqs (2.1)–(2.4) to zero and solving for (S,I,V,ϕ). Our model demonstrates that the SIV model can be reduced to the SIV framework in the extreme cases of zero or all vaccinations. We also include a unique complex balanced fear steady state (BFSS). The steady states can be illustrated in the phase portrait (Figure 8) and the corresponding Table 2. Note the steady states and their stability depend on the initial conditions and parameter values.

    Figure 8.  A) The phase portrait of the different regions within the triangular prism (top view) was obtained by evaluating the sign of the Eqs (2.3) and (2.4). Each of the regions is obtained by solving for the nullclines and partitioning the polygon from the bottom plane (S-I nullcline), top plane (I-V nullcline), and vertical plane (ϕ). The steady states are labeled around the triangular prism and correspond to those listed in (Table ???). The SV steady state is not within the polygon due to the parameter values. B) Conditions corresponding to the different regions within the polygon where ΔE flips signs.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This work was partially supported by Public Health Service grants 1R01EY028450 from NIH/NEI, the endowment for the Frady Whipple Chair in Mathematics at Georgia State University (to Y.J.), the endowment for the Evelyn and John G. Phillips Distinguished Chair in Mathematics at Tulane University and R01HD086794 from the NIH/NICHD and U01GM09658 from the NIH/NIGMS/MIDAS (to JMH), and a 2CI PhD Fellowship from Georgia State University (to AM). RKPZ acknowledges valuable discussions with Kevin Bassler and Hedda Grelz.

    The authors declare there is no conflict of interest. Yi Jiang is an editorial board member for Mathematical Biosciences and Engineering and was not involved in the editorial review or the decision to publish this article.



    [1] WHO, Ten Threats to Global Health in 2019. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
    [2] Department of Health and Human Services, COVID-19 Vaccine Distribution: the Process. Available from: https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html.
    [3] W. Daniel, M. Nivet, J. Warner, D. K. Podolsky, Early evidence of the effect of SARS-CoV-2 vaccine at one medical center, N. Engl. J. Med., 384 (2021), 1962–1963. https://doi.org/10.1056/NEJMc2102153 doi: 10.1056/NEJMc2102153
    [4] Centers for Disease Control and Prevention, COVID Data Tracker. Available from: https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
    [5] Johns Hopkins Coronavirus Resource Center, Impact of Opening and Closing Decisions by State: A Look at How Social Distancing Measures May Have Inffuenced Trends in COVID-19 Cases and Death. Available from: https://coronavirus.jhu.edu/data/state-timeline.
    [6] J. V. Lazarus, S. C. Ratzan, A. Palayew, L. O. Gostin, H. J. Larson, K. Rabin, et al., A global survey of potential acceptance of a COVID-19 vaccine, Nat. Med., 27 (2021), 225–228. https://doi.org/10.1038/s41591-020-1124-9 doi: 10.1038/s41591-020-1124-9
    [7] C. J. L. Murray, P. Piot, The potential future of the COVID-19 pandemic: Will SARS-CoV-2 become a recurrent seasonal infection?, JAMA, 325 (2021), 1249–1250. https://doi.org/10.1001/jama.2021.2828 doi: 10.1001/jama.2021.2828
    [8] J. McAteer, I. Yildirim, A. Chahroudi, The VACCINES Act: Deciphering vaccine hesitancy in the time of COVID-19, Clin. Infect. Dis., 71 (2020), 703–705. https://doi.org/10.1093/cid/ciaa433 doi: 10.1093/cid/ciaa433
    [9] A. A. Dror, N. Eisenbach, S. Taiber, N. G. Morozov, M. Mizrachi, A. Zigron, et al., Vaccine hesitancy: the next challenge in the ffght against COVID-19, Eur. J. Epidemiol., 35 (2020), 775–779. https://doi.org/10.1007/s10654-020-00671-y doi: 10.1007/s10654-020-00671-y
    [10] K. O. Kwok, K. K. Li, W. I. Wei, A. Tang, S. Y. S. Wong, S. S. Lee, Inffuenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey, Int. J. Nurs. Stud., 114 (2021), 103854. https://doi.org/10.1007/s10654-020-00671-y doi: 10.1007/s10654-020-00671-y
    [11] R. Goodwin, M. Ben-Ezra, M. Takahashi, L. A. N. Luu, K. Borsfay, M. Kovács, et al., Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary, Sci. Rep., 12 (2022), 439. https://doi.org/10.1038/s41598-021-03986-2 doi: 10.1038/s41598-021-03986-2
    [12] J. V. Lazarus, S. C. Ratzan, A. Palayew, L. O. Gostin, H. J. Larson, K. Rabin, et al., A global survey of potential acceptance of a COVID-19 vaccine, Nat. Med., 27 (2021), 225–228. https://doi.org/10.1038/s41591-020-1124-9 doi: 10.1038/s41591-020-1124-9
    [13] E. Robinson, A. Jones, I. Lesser, M. Daly, International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples, Vaccine, 39 (2021), 2024–2034. https://doi.org/10.1038/s41591-020-1124-9 doi: 10.1038/s41591-020-1124-9
    [14] D. Freeman, B. Loe, A. Chadwick, C. Vaccari, F. Waite, L. Rosebrock, et al., COVID-19 vaccine hesitancy in the UK: the oxford coronavirus explanations, attitudes, and narratives survey (oceans) II, Psychol. Med., 52 (2022), 3127–3141. https://doi.org/10.1017/S0033291720005188 doi: 10.1017/S0033291720005188
    [15] C. Ghaznavi, D. Yoneoka, T. Kawashima, A. Eguchi, M. Murakami, S. Gilmour, et al., Factors associated with reversals of COVID-19 vaccination willingness: Results from two longitudinal, national surveys in Japan 2021–2022, Lancet Reg. Health–West. Paciffc, 27 (2022), 1–13. https://doi.org/10.1016/j.lanwpc.2022.100540 doi: 10.1016/j.lanwpc.2022.100540
    [16] M. Walkowiak, J. Domaradzki, D. Walkowiak, Are we facing a tsunami of vaccine hesitancy or outdated pandemic policy in times of omicron? analyzing changes of COVID-19 vaccination trends in Poland, Vaccines, 11 (2022), 1065. https://doi.org/10.3390/vaccines11061065 doi: 10.3390/vaccines11061065
    [17] J. Stoler, C. A. Klofstad, A. M. Enders, J. E. Uscinski, Sociopolitical and psychological correlates of COVID-19 vaccine hesitancy in the United States during summer 2021, Social Sci. Med., 306 (2022), 115112. https://doi.org/10.1016/j.socscimed.2022.115112 doi: 10.1016/j.socscimed.2022.115112
    [18] A. M. Enders, J. Uscinski, C. Klofstad, J. Stoler, On the relationship between conspiracy theory beliefs, misinformation, and vaccine hesitancy, PLoS One, 17 (2022), e0276082. https://doi.org/10.1371/journal.pone.0276082 doi: 10.1371/journal.pone.0276082
    [19] J. Uscinski, A. M. Enders, C. Klofstad, J. Stoler, Cause and effect: On the antecedents and consequences of conspiracy theory beliefs, Curr. Opin. Psychol., 47 (2022), 101364. https://doi.org/10.1016/j.copsyc.2022.101364 doi: 10.1016/j.copsyc.2022.101364
    [20] J. Murphy, F. Vallières, R. P. Bentall, M. Shevlin, O. McBride, T. K. Hartman, et al., Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom, Nat. Commun., 12 (2021), 29. https://doi.org/10.1038/s41467-020-20226-9 doi: 10.1038/s41467-020-20226-9
    [21] S. Hummert, K. Bohl, D. Basanta, A. Deutsch, S. Werner, G. Theissen, et al., Evolutionary game theory: cells as players, Mol. Biosyst., 10 (2014), 3044–3065. https://doi.org/10.1039/C3MB70602H doi: 10.1039/C3MB70602H
    [22] T. L. Vincent, J. S. Brown, Stability in an evolutionary game, Theor. Popul. Biol., 26 (1984), 408–427. https://doi.org/10.1039/C3MB70602H doi: 10.1039/C3MB70602H
    [23] J. Hofbauer, K. Sigmund, Evolutionary game dynamics, Bull. Am. Math. Soc., 40 (2003), 479–519. https://doi.org/10.1090/S0273-0979-03-00988-1
    [24] C. T. Bauch, D. J. D. Earn, Vaccination and the theory of games, in Proceedings of the National Academy of Sciences of the United States of America, 101 (2004), 13391–13394. https://doi.org/10.1073/pnas.0403823101
    [25] B. Rahman, E. Sadraddin, A. Porreca, The basic reproduction number of SARS-CoV-2 in wuhan is about to die out, how about the rest of the world, Rev. Med. Virol., 30 (2020), e2111. https://doi.org/10.1002/rmv.2111 doi: 10.1002/rmv.2111
    [26] M. A. Billah, M. M. Miah, M. N. Khan, Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence, PLoS One, 15 (2020), e0242128. https://doi.org/10.1371/journal.pone.0242128 doi: 10.1371/journal.pone.0242128
    [27] H. Rossman, S. Shilo, T. Meir, M. Gorffne, U. Shalit, E. Segal, COVID-19 dynamics after a national immunization program in Israel, Nat. Med., 27 (2021), 1055–1061. https://doi.org/10.1038/s41591-021-01337-2 doi: 10.1038/s41591-021-01337-2
    [28] M. Voysey, S. A. C. Clemens, S. A. Madhi, L. Y. Weckx, P. M. Folegatti, P. K. Aley, et al., Single-dose administration and the inffuence of the timing of the booster dose on immunogenicity and efffcacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, Lancet, 397 (2021), 881–891. https://doi.org/10.1016/S0140-6736(21)00432-3 doi: 10.1016/S0140-6736(21)00432-3
    [29] C. Luo, C. Morris, J. Sachithanandham, A. Amadi, D. Gaston, M. Li, et al., Infection with the SARS-CoV-2 delta variant is associated with higher infectious virus loads compared to the alpha variant in both unvaccinated and vaccinated individuals, medRxiv, 2021. https://doi.org/10.1101/2021.08.15.21262077
    [30] M. Lipsitch, SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact, Nat. Rev. Immunol., 22 (2022), 57–65. https://doi.org/10.1038/s41577-021-00662-4 doi: 10.1038/s41577-021-00662-4
    [31] B. A. Cohn, P. M. Cirillo, C. C. Murphy, N. Y. Krigbaum, A. W. Wallace, SARS-CoV-2 vaccine protection and deaths among us veterans during 2021, Science, 375 (2022), 331–336. https://doi.org/10.1126/science.abm0620 doi: 10.1126/science.abm0620
    [32] S. T. Tan, A. T. Kwan, I. Rodríguez-Barraquer, B. J. Singer, H. J. Park, J. A. Lewnard, et al., Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave, Nat. Med., 29 (2023), 358–365. https://doi.org/10.1038/s41591-022-02138-x doi: 10.1038/s41591-022-02138-x
    [33] F. Guerra, S. Bolotin, G. Lim, J. Heffernan, S. Deeks, Y. Li, et al., The basic reproduction number (R0) of measles: a systematic review, Lancet Infect. Dis., 17 (2017), e420. https://doi.org/10.1016/S1473-3099(17)30307-9 doi: 10.1016/S1473-3099(17)30307-9
    [34] Y. Liu, J. Rocklöv, The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta, J. Travel Med., 29 (2022), taac037. https://doi.org/10.1093/jtm/taac037 doi: 10.1093/jtm/taac037
    [35] T. Randall, COVID Still Killing Americans Faster Than Guns, Cars and Flu Combined. Available from: https://www.bloomberg.com/news/articles/2021-07-16/how-many-COVID-deaths-still-more-than-guns-car-crashes-and-flu?leadSource = uverify%20wall.
    [36] University of Cambridge, How Have COVID-19 Fatalities Compared with Other Causes of Death. Available from: https://wintoncentre.maths.cam.ac.uk/coronavirus/how-have-COVID-19-fatalities-comparedother-causes-death/.
    [37] K. M. Jia, W. P. Hanage, M. Lipsitch, A. G. Johnson, A. B. Amin, A. R. Ali, et al., Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States, Eur. J. Epidemiol., 38 (2023), 1125–1128. https://doi.org/10.1007/s10654-023-01006-3 doi: 10.1007/s10654-023-01006-3
    [38] K. Y. Ng, M. M. Gui, COVID-19: Development of a robust mathematical model and simulation package with consideration for ageing population and time delay for control action and resusceptibility, Physica D, 411 (2020), 132599. https://doi.org/10.1016/j.physd.2020.132599 doi: 10.1016/j.physd.2020.132599
    [39] M. Angeli, G. Neofotistos, M. Mattheakis, E. Kaxiras, Modeling the effect of the vaccination campaign on the COVID-19 pandemic, Chaos, Solitons Fractals, 154 (2022), 111621. https://doi.org/10.1016/j.chaos.2021.111621 doi: 10.1016/j.chaos.2021.111621
    [40] T. Tsuruyama, Nonlinear model of infection wavy oscillation of COVID-19 in Japan based on diffusion kinetics, Sci. Rep., 12 (2022), 19177. https://doi.org/10.1038/s41598-022-23633-8 doi: 10.1038/s41598-022-23633-8
    [41] N. J. Stroud, Media use and political predispositions: Revisiting the concept of selective exposure, Polit. Behav., 30 (2008), 341–366. https://doi.org/10.1007/s11109-007-9050-9 doi: 10.1007/s11109-007-9050-9
    [42] N. J. Stroud, Polarization and partisan selective exposure, J. Commun., 60 (2010), 566–576. https://doi.org/10.1111/j.1460-2466.2010.01497.x doi: 10.1111/j.1460-2466.2010.01497.x
    [43] N. J. Stroud, E. Thorson, D. Young, Making sense of information and judging its credibility, in Understanding and Addressing the Disinformation Ecosystem, (2017), 45–50.
  • Reader Comments
  • © 2024 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1220) PDF downloads(62) Cited by(0)

Figures and Tables

Figures(8)  /  Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog